Innovative Bioengineering Platforms for Cancer Therapeutics: From Models to Screening
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 114
Special Issue Editor
Interests: transcription; metabolism; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in bioengineering have revolutionized cancer research, providing innovative tools for modeling the tumor microenvironment, discovering new drug candidates, and optimizing treatment strategies. This Special Issue will highlight applications of cutting-edge bioengineering technologies in cancer biology and drug discovery, including 3D culture models, organoids, organ-on-a-chip systems, high-throughput drug screening, computational and AI-based prediction, and microfluidic platforms. We welcome original research articles, reviews, and perspectives focusing on the design, application, and translational potential of bioengineered systems for cancer drug development and personalized oncology.
Dr. Eriko Katsuta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer drug screening
- tumor microenvironment
- 3D culture/organoids
- microfluidics/organ-on-a-chip
- AI-based drug discovery
- bioinformatics and modeling
- precision oncology
- systems biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
